Jeremy Bender is the founder of Day One Biopharmaceuticals. Day One Biopharmaceuticals has raised $374M in total funding. Latest round: IPO.
Jeremy Bender is the founder and leader of Day One Biopharmaceuticals, a company focused on pediatric oncology. Under his leadership, Day One obtained its first FDA approval in April 2024 for its first product, apanib. He has guided the company through multiple funding rounds, including a $60 million Series A in 2020, a $130 million Series B in 2021, and an IPO in May that brought in $184 million.
Full founder directory · Investor directory · Company funding database · Fundraising library